News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MaxCyte, Inc. Presents Data On Stable Cell Line Generation And Rapid, High Titer Production Of Antibodies And Proteins Using Flow Electroporation



12/9/2013 9:37:13 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MaxCyte®, Inc., the pioneer in scalable, high-performance cell transfection systems, will be presenting data demonstrating dramatic reductions in antibody development timelines by enabling large-scale transient gene expression directly within cells commonly used in commercial protein production. The presentation will be made at IBC’s 24th Annual Antibody Engineering and Therapeutics Meeting, held December 8-12, 2013 at the Hyatt Regency Huntington Beach Resort & Spa, CA.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES